|
|
Volumn 9, Issue 6, 2000, Pages 1383-1396
|
|
TNP-470: An angiogenesis inhibitor in clinical development for cancer
|
|
Author keywords
AGM 1470; Angiogenesis; Cancer; Fumagillin; Neovascularisation; Therapy; Tumours
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
FUMAGILLOL CHLOROACETYLCARBAMATE;
METHIONINE AMINOPEPTIDASE 2;
PEPTIDASE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AMNESIA;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ATAXIA;
BRAIN CANCER;
BREAST CANCER;
CANCER;
CLINICAL TRIAL;
CONFUSION;
DOG;
FATIGUE;
FEMALE;
HUMAN;
HUMAN CELL;
KAPOSI SARCOMA;
KIDNEY CANCER;
MALE;
NEUTROPENIA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RAT;
REVIEW;
UTERINE CERVIX CANCER;
VERTIGO;
WOUND HEALING;
|
|
EID: 0034120430
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.9.6.1383 Document Type: Review |
|
Times cited : (127)
|
|
References (100)
|
